Drug consumption and melanocytic nevi: correlation between oral contraceptives or hormone replacement therapy and a high melanocytic nevi count.
Adult
Aged
Case-Control Studies
Contraceptives, Oral
/ adverse effects
Dermoscopy
/ statistics & numerical data
Female
Hormone Replacement Therapy
/ adverse effects
Humans
Male
Middle Aged
Nevus, Pigmented
/ diagnosis
Retrospective Studies
Risk Factors
Severity of Illness Index
Skin
/ diagnostic imaging
Skin Neoplasms
/ diagnosis
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
1
10
2019
medline:
10
7
2021
entrez:
1
10
2019
Statut:
ppublish
Résumé
The prolonged use of drugs such as beta-blockers, acetylsalicylic acid, omeprazole, statins, oral contraceptives and hormone replacement therapy might have some role in melanocytic nevi development and be ultimately linked to melanoma risk. Aims of the study were to evaluate a possible association between the above-mentioned drugs and features such as number and atypia of melanocytic nevi in long-term users. We retrospectively looked at pharmacological, clinical and dermoscopic records of 1321 patients that attended our unit for routine mole check between January 2013 and January 2018. Patients were divided into two groups (low or high melanocytic nevi count), and multivariate analysis was performed with regards to the presence and number of melanocytic nevi and drug assumption. A positive association between the use of oral contraceptives or hormone replacement therapy (P = 0.012) and a high melanocytic nevi count was found through multivariate analysis, after adjusting for sex, age and multiple confounding factors, such as freckles, phototype and a reported history of sun exposure and sunburns. Further prospective studies are necessary to establish whether women using oral contraceptives or on hormone replacement therapy should undergo periodic monitoring of pigmented lesions.
Identifiants
pubmed: 31567537
doi: 10.1097/CEJ.0000000000000545
pii: 00008469-202007000-00009
doi:
Substances chimiques
Contraceptives, Oral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
338-341Références
Borges V, Puig S, Malvehy J. Melanocytic nevi, melanoma, and pregnancy[in Spanish]. Actas Dermosifiliogr. 2011; 102:650–657
De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N, Geppetti P. Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death. Mayo Clin Proc. 2013; 88:1196–1203
Echeverria BJ, Bulliard L, Guill C, Nagore E. Indicators for the total number of melanocytic naevi: an adjunct for screening campaigns. Observational study on 292 patients. Br J Dermatol. 2014; 70:144–149
Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, et al. Aspirin is associated with lower melanoma risk among postmenopausal caucasian women: the women’s health initiative. Cancer. 2013; 119:1562–1569
Gandini S, Iodice S, Koomen E, Di Pietro A, Sera F, Caini S. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer. 2011; 47:2607–2617
Jee SH, Lee SY, Chiu HC, Chang CC, Chen T. Effects of estrogen and estrogen receptor in normal human melanocytes. Biochem Biophys Res Commun. 1994; 199:1407–1412
Marino ML, Fais S, Djavaheri-Mergny M, Villa A, Meschini S, Lozupone F, et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis. 2010; 1:e87
Ohata C, Tadokoro T, Itami S. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas. J Dermatol. 2008; 35:215–221
Pich C, Teiti I, Rochaix P, Mariamé B, Couderc B, Favre G, Tilkin-Mariamé A. Statins reduce melanoma development and metastasis through MICA overexpression. Front Immunol. 2013; 4:62
Wiedemann C, Nägele U, Schramm G, Berking C. Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro. Contraception. 2009; 80:292–298